SPONSORED:

Schumer: 'Very good chance' Price won't be confirmed

Schumer: 'Very good chance' Price won't be confirmed
© Getty Images

Senate Minority Leader Charles SchumerChuck SchumerBiden to meet with GOP senators amid infrastructure push The Hill's Morning Report - Presented by Emergent BioSolutions - Upbeat jobs data, relaxed COVID-19 restrictions offer rosier US picture How to fast-track climate action? EPA cutting super pollutant HFCs MORE (D-N.Y.) predicted Tuesday that backlash over concerns about Rep. Tom Price’s (R-Ga.) previous investments could sink his nomination to lead the Department of Health and Human Services.

"I think there's a very good chance he will not be confirmed," Schumer told CNN.

CNN reported on Monday that Price invested in a medical device company shortly before introducing legislation that benefited the company.

ADVERTISEMENT

President-elect Donald TrumpDonald TrumpThe Memo: The Obamas unbound, on race Iran says onus is on US to rejoin nuclear deal on third anniversary of withdrawal Assaults on Roe v Wade increasing MORE's transition team has dismissed the CNN report, noting that a broker made the investment and Price wasn't aware of it until after he introduced the legislation.

But Schumer floated Tuesday that Price may have broken the law if he knew about the investment.

"That cries out for an investigation," Schumer told CNN. "If he knew about it, it could very well be a violation of the law."

Democrats would need Republican support to block Price's nomination. He'll need 50 votes to clear the upper chamber, and Republicans hold a 52-seat majority.

Price is scheduled to testify Wednesday before the Senate Health, Education, Labor and Pensions Committee. He will also face the Senate Finance Committee, though a date for that hearing has not yet been set.

Democratic Sens. Al FrankenAlan (Al) Stuart FrankenMaher chides Democrats: We 'suck the fun out of everything' Why Caitlyn Jenner should not be dismissed #MeWho? The hypocritical silence of Kamala Harris MORE (Minn.), Elizabeth WarrenElizabeth WarrenFree Speech Inc.: The Democratic Party finds a new but shaky faith in corporate free speech Debate over ICBMs: Will 'defund our defenses' be next? Manchin on collision course with Warren, Sanders MORE (Mass.) and Tammy BaldwinTammy Suzanne BaldwinSenate Democrats push Biden over raising refugee cap House Dems to unveil drug pricing measure ahead of Biden package World passes 3 million coronavirus deaths MORE (Wis.) are asking for the hearing to be delayed over the ethics allegations.